- CEO
- Lei Xu
- Full Time Employees
- 2,803
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- No. 1, Dongjiu Road Tianjin TI China 300308
- IPO Date
- Sep 3, 2010
- Business
- Tianjin Ringpu Bio-Technology Co.,Ltd. is a prominent entity in the biotechnology and animal health sector, dedicated to the research, development, manufacturing, and distribution of a comprehensive array of veterinary biological products and pharmaceuticals within China and internationally. The company provides an extensive portfolio of vaccines and medications for various animal categories, including poultry, swine, aquatic life, cattle, sheep, and companion animals. Its offerings for pets encompass rabies inactivated vaccines, recombinant canine-a interferon, anesthetic agents like isoflurane and sevoflurane, and specialized treatments for bacterial diseases and heart conditions. For waterfowl, products include vaccines for duck tempusu and duck infectious serositis, along with refined egg yolk antibodies for gosling plague and duck viral hepatitis. Beyond specific animal applications, Tianjin Ringpu also supplies functional additives, such as natural plant extracts, immune polysaccharides, probiotics like Clostridium butyricum and Lactobacillus plantarum, enzyme preparations, and acidulants. The company further extends its reach with disinfection and cleaning solutions, as well as active pharmaceutical ingredients (APIs) like tilmicosin and florfenicol. Engaging in agricultural biotechnology, the firm also develops microbial agents, bio-fertilizers, and plant growth promoters to enhance farming productivity. With a strong commitment to innovation, Tianjin Ringpu allocates a significant portion of its revenue to research and development, which has led to breakthroughs like receiving clinical trial approval for China's first mRNA vaccine for economic animals in July 2025. Operating with a robust distribution network, the company serves livestock farmers, veterinary clinics, and pharmaceutical distributors across multiple countries. Established in 1998 and headquartered in Tianjin, China, the company is listed on the Shenzhen Stock Exchange.